科济药业纳入MSCI全球小盘股中国地区指数

证券日报11-10

本报讯（记者陈潇）11月6日，国际指数编制公司明晟（MSCI）公布2025年11月份指数审议结果，调整将于11月24日收盘后正式生效。本次调整中，MSCI全球小盘股指数新增22只个股，科济药业控股有限公司（以下简称“科济药业-B”，股票代码：2171.HK）成功入选。　　此前，科济药业-B已被纳入MSCI香港小型股指数，本次调整系其由香港地区指数纳入中国地区指数。据悉，MSCI指数受到全球机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2582479928?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-10 15:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582479928","market":"hk","top_or_hot":-1,"title":"科济药业纳入MSCI全球小盘股中国地区指数","media":"证券日报","content":"<div>\n<p>本报讯 （记者陈潇）11月6日，国际指数编制公司明晟（MSCI）公布2025年11月份指数审议结果，调整将于11月24日收盘后正式生效。本次调整中，MSCI全球小盘股指数新增22只个股，科济药业控股有限公司（以下简称“科济药业-B”，股票代码：2171.HK）成功入选。　　此前，科济药业-B已被纳入MSCI香港小型股指数，本次调整系其由香港地区指数纳入中国地区指数。据悉，MSCI指数受到全球机构...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202511103559722423.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科济药业纳入MSCI全球小盘股中国地区指数</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科济药业纳入MSCI全球小盘股中国地区指数\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-10 15:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202511103559722423.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>本报讯 （记者陈潇）11月6日，国际指数编制公司明晟（MSCI）公布2025年11月份指数审议结果，调整将于11月24日收盘后正式生效。本次调整中，MSCI全球小盘股指数新增22只个股，科济药业控股有限公司（以下简称“科济药业-B”，股票代码：2171.HK）成功入选。　　此前，科济药业-B已被纳入MSCI香港小型股指数，本次调整系其由香港地区指数纳入中国地区指数。据悉，MSCI指数受到全球机构...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202511103559722423.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289739343.SGD","symbol_name":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","start_time":0,"source_url":"http://finance.eastmoney.com/a/202511103559722423.html","article_id":"2582479928","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582479928","pubTimestamp":1762758314,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"本报讯（记者陈潇）11月6日，国际指数编制公司明晟（MSCI）公布2025年11月份指数审议结果，调整将于11月24日收盘后正式生效。本次调整中，MSCI全球小盘股指数新增22只个股，科济药业控股有限公司（以下简称“科济药业-B”，股票代码：2171.HK）成功入选。此前，科济药业-B已被纳入MSCI香港小型股指数，本次调整系其由香港地区指数纳入中国地区指数。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK1574":"生物医药B类股","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","02171":"科济药业-B","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK4588":"碎股","BK4112":"金融交易所和数据","BK1585":"昨日强势股","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","BK4585":"ETF&股票定投概念","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","BK1161":"生物科技","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","MSCI":"MSCI Inc","BK1587":"次新股"},"translate_title":"Keji Pharmaceutical included in MSCI Global Small-Cap China Index","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MSCI":1.5,"02171":1.5},"content_text":"本报讯 （记者陈潇）11月6日，国际指数编制公司明晟（MSCI）公布2025年11月份指数审议结果，调整将于11月24日收盘后正式生效。本次调整中，MSCI全球小盘股指数新增22只个股，科济药业控股有限公司（以下简称“科济药业-B”，股票代码：2171.HK）成功入选。　　此前，科济药业-B已被纳入MSCI香港小型股指数，本次调整系其由香港地区指数纳入中国地区指数。据悉，MSCI指数受到全球机构投资者的广泛追踪和参考，指数调整主要依据市值、流动性等客观量化指标，个股纳入通常被视为获得全球资本市场认可的信号，有望吸引被动资金配置，为相关上市公司带来流动性提升机遇。　　作为中国生物医药CGT领域的领军企业，科济药业不断致力于在治疗血液恶性肿瘤和实体瘤的创新CAR-T细胞疗法上实现新突破。近期，科济药业董事长李宗海在采访中表示，科济药业始终围绕CAR-T赛道的关键挑战做创新，一是攻克难治肿瘤，二是降低治疗成本，让更多老百姓用得起。　　此次公司获纳入MSCI全球小盘股指数，有望使科济药业-B获得更多全球资金关注，进一步提升股票流动性及市场估值水平。（文章来源：证券日报）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582479928","isCrawlerRequest":true}